Activity report of the INCa-designated early-phase clinical trial centres (CLIP²) 2010-2012

Key points - Method - Summary of activity data - Review of collaboration with the National Cancer Institute (NCI) - Review of collaboration with pharmaceutical companies - Conclusions and outlook.

  • Collection : Appui à la décision
  • Public : Professionnels de la recherche / Professionnels de santé
  • Publication Date :
  • Reference : BILCLIPP14ANG
  • Format : Brochure A4
  • Language : Anglais